Diagnose Early is the result of a transformative merger between Sonasoft Corp. and Diagnose Early, Inc., combining Sonasoft’s AI health data platform with Diagnose Early’s proprietary breath analysis. Diagnose Early now offers the only health data ecosystem to deliver data-driven preventative healthcare by combining non-invasive breath analysis with a proprietary AI health data platform.
A world where AI lets everyone understand their individual health risks, eliminating the need for reactive treatment of diseases and medical conditions
To give all our users personalized data-driven preventative healthcare using AI to process the rich and diverse health data we collect
We are helping reshape the future of health diagnostics by developing non-invasive breath and biometric testing, powered by our groundbreaking AI technology. Our breath test is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat. This is backed up by other tests including finger-prick blood testing.
The Diagnose Early Health Data Platform collects users’ complete health data and test results in one place, providing them with a health time machine for the future.
This data can be analyzed by our proprietary AI to identify key risks or shared with researchers to help deliver novel treatments and preventative healthcare.
Our world-class team is at the forefront of healthcare technology and innovation, making a tangible difference to people's lives and propelling our vision into a transformative reality.
Diagnose Early is lead by a highly experienced leadership team with a strong background in health data and medical devices